Careprost Eye Drops 0.03% (Bimatoprost)
The active ingredient present in Careprost Eye Drops is Bimatoprost. Careprost Ophthalmic Solution contains 0.03% of Bimatoprost. Careprost Eye Drops is used to treat high eye pressure (intraocular pressure) in patients with open angle glaucoma or ocular hypertension and for increasing thickness and length of eyelashes. Careprost ophthalmic solution is manufactured in the strengths of 0.03% of Bimatoprost.
Careprost eye drops 0.03% is an ophthalmic solution used to lower pressure within the eye, known as intraocular pressure (IOP) in the treatment of glaucoma, which is raised IOP caused by a build up of fluid (aqueous humour) in the eye. Increased IOP can cause damage to the optic nerve fibres that lead out of the back of the eye to the brain and may cause gradual loss of sight, starting with peripheral vision and eventually to total blindness in that eye. Careprost 0.03% increases the drainage of aqueous fluid out of the eye which decreases IOP and prevents loss of sight. Careprost eye drops are also used to treat ocular hypertension (increased IOP without ocular nerve damage) to lower IOP. Careprost eye drops 0.03% are also used to treat hypotrichosis, which is when eyelash growth is abnormal or not sufficient to give you adequate or enough eyelashes, and allows you to grow longer, thicker and darker eyelashes.
Mechanism of action
Careprost eye drops 0.03% (also known as Lumigan and Latisse in the US) contain bimatoprost, a synthetic analogue (mimic) of the naturally occurring prostamide, which is a prostaglandin-like chemical that has distinct and specific actions in various tissues of the body, including potent ocular hypotensive (pressure reducing) activity. The build up of pressure in the eye that is seen in glaucoma is caused by a blockage in the draining system for the eye fluid called aqueous humour, which is produced continually to maintain normal eye pressure. Bimatoprost in Careprost 0.03% binds to the same receptors in the eye as prostamide and increases the flow of aqueous humour out of the eye through the spongy tissue called the trabecular network, which is the conventional drainage route for the aqueous, by reducing the tonographic (pressure-sensitive) resistance to outflow of aqueous humour and opening up the trabecular mesh for fluid drainage. As the flow of fluid into and out of the eye becomes balanced again, the pressure in the eye is lowered and this reduces the risk of damage to the optic nerve and loss of sight that can happen if glaucoma is left untreated.
No other eye drops or ointments should be given no less than 5 minutes before or after Bimatoprost ophthalmic solution(Careprost Eye Drops).
The recommended dosage of Lumigan is one drop in the affected eye(s) once daily in the evening.
For increasing thickness and length of eyelashes, it is administered once daily by applying Careprost ophthalmic solution to the skin at the base of the upper eyelash line using an applicator device where it has its effect upon the hair follicle.
The most common side effects of Careprost Eye Drops is conjunctival hyperemia, a condition which involves redness especially of the sclera.
Get emergency medical help if you have any signs of an allergic reaction including: hives, difficulty breathing, and swelling of your face, lips, tongue, or throat.
Stop using Bimatoprost ophthalmic solution and call your doctor at once if you have any of these serious side effects:
• redness, swelling, itching, or pain in or around your eye
Precautions and warnings
- Do not use Careprost if you are allergic to any of its ingredients in bimatoprost or if you have known allergies. Inactive ingredients in Careprost may also trigger an allergic reaction.
- Consult with your doctor about your medical history especially if you have glaucoma or other eye problems before applying Careprost.
- Other eye conditions that should be considered before using Careprost include macular edema, lens extraction, and iritis.
- Get medical attention promptly if you develop an infection in your eye or any other eye condition because Careprost could cause additional harm.
- Careprost may change the pigmentation of the eyelid; this change may be temporary or reversible when the use of Careprost is stopped.